EW vs MO · P/E 47, rev $1.39B vs P/E 14, rev $23.28B
Edwards Lifesciences Corp (EW) versus Altria Group (MO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Altria Group (MO) is a tobacco company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Not investment advice. Open the EW and MO stock pages for the full models.
Not investment advice.